Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome

Patient‐specific induced pluripotent stem cells (iPSCs) will assist research on genetic cardiac maladies if the disease phenotype is recapitulated in vitro. However, genetic background variations may confound disease traits, especially for disorders with incomplete penetrance, such as long‐QT syndromes (LQTS). To study the LQT2‐associated c.A2987T (N996I) KCNH2 mutation under genetically defined conditions, we derived iPSCs from a patient carrying this mutation and corrected it. Furthermore, we introduced the same point mutation in human embryonic stem cells (hESCs), generating two genetically distinct isogenic pairs of LQTS and control lines. Correction of the mutation normalized the current (IKr) conducted by the HERG channel and the action potential (AP) duration in iPSC‐derived cardiomyocytes (CMs). Introduction of the same mutation reduced IKr and prolonged the AP duration in hESC‐derived CMs. Further characterization of N996I‐HERG pathogenesis revealed a trafficking defect. Our results demonstrated that the c.A2987T KCNH2 mutation is the primary cause of the LQTS phenotype. Precise genetic modification of pluripotent stem cells provided a physiologically and functionally relevant human cellular context to reveal the pathogenic mechanism underlying this specific disease phenotype.

[1]  M. Gerstein,et al.  Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells , 2012, Nature.

[2]  Derick R. Peterson,et al.  Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel , 2002, Circulation.

[3]  Donald M Bers,et al.  Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.

[4]  Christine L Mummery,et al.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. , 2012, Circulation research.

[5]  G. Daley,et al.  Reprogrammed cells for disease modeling and regenerative medicine. , 2013, Annual review of medicine.

[6]  D. Goldstein.  Common genetic variation and human traits. , 2009, The New England journal of medicine.

[7]  U. Bonuccelli,et al.  IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients , 2012, Autism research and treatment.

[8]  D. Tester,et al.  Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome. , 2004, Heart rhythm.

[9]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[10]  Susan Lindquist,et al.  Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.

[11]  Haiyan Mao,et al.  Trafficking-Deficient G572R-hERG and E637K-hERG Activate Stress and Clearance Pathways in Endoplasmic Reticulum , 2012, PloS one.

[12]  D. Rujescu,et al.  A novel, primate-specific, brain isoform of KCNH2 impacts cortical physiology, cognition, neuronal repolarization and risk for schizophrenia , 2009, Nature Medicine.

[13]  Stéphanie Boué,et al.  Methods for making induced pluripotent stem cells: reprogramming à la carte , 2011, Nature Reviews Genetics.

[14]  C. Mummery,et al.  Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias , 2012, Front. Physio..

[15]  C. Mummery,et al.  Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease , 2012, Circulation.

[16]  Daniel C Bartos,et al.  Trafficking-deficient hERG K⁺ channels linked to long QT syndrome are regulated by a microtubule-dependent quality control compartment in the ER. , 2011, American journal of physiology. Cell physiology.

[17]  E. Stanley,et al.  A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis , 2008, Nature Protocols.

[18]  Zhao Zhang,et al.  A422T mutation in HERG potassium channel retained in ER is rescurable by pharmacologic or molecular chaperones. , 2012, Biochemical and biophysical research communications.

[19]  J. I. Izpisúa Belmonte,et al.  iPSCs: induced back to controversy. , 2011, Cell stem cell.

[20]  Shinsuke Yuasa,et al.  Disease characterization using LQTS-specific induced pluripotent stem cells. , 2012, Cardiovascular research.

[21]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[22]  Torsten Kluba,et al.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. , 2013, Cell stem cell.

[23]  Bba,et al.  Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene , 2007, Circulation.

[24]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[25]  Jae-Hyung Jang,et al.  Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  Hynek Wichterle,et al.  A functionally characterized test set of human induced pluripotent stem cells , 2011, Nature Biotechnology.

[27]  Joseph C. Wu,et al.  Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  Fred H. Gage,et al.  Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.

[29]  Ron Prywes,et al.  The Luminal Domain of ATF6 Senses Endoplasmic Reticulum (ER) Stress and Causes Translocation of ATF6 from the ER to the Golgi* , 2002, The Journal of Biological Chemistry.

[30]  M. Brizzi,et al.  HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors , 2002, Leukemia.

[31]  M. Leyne,et al.  Kinetin Improves IKBKAP mRNA Splicing in Patients With Familial Dysautonomia , 2011, Pediatric Research.

[32]  Karl-Ludwig Laugwitz,et al.  Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Versatile Tool for Arrhythmia Research , 2013, Circulation research.

[33]  Marek Michalak,et al.  Quality control in the endoplasmic reticulum. , 2010, Seminars in cell & developmental biology.

[34]  H. R. Lu,et al.  Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes. , 2013, Stem Cell Research.

[35]  R. H. Scofield,et al.  Western Blotting , 2015, Methods in Molecular Biology.

[36]  Martin Pera,et al.  A method for genetic modification of human embryonic stem cells using electroporation , 2007, Nature Protocols.

[37]  Julie V. Harness,et al.  Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. , 2012, Cell stem cell.

[38]  D. Tester,et al.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. , 2005, Heart rhythm.

[39]  A. Moss,et al.  Genotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome: Possible Therapy Implications , 2006, Circulation.

[40]  Y. Rudy.  Molecular Basis of Cardiac Action Potential Repolarization , 2008, Annals of the New York Academy of Sciences.

[41]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[42]  M. Goumans,et al.  Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype. , 2010, Journal of molecular and cellular cardiology.

[43]  Francisco M. De La Vega,et al.  Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. , 2009, Genome research.

[44]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[45]  S. Yamanaka,et al.  Induction of pluripotent stem cells from fibroblast cultures , 2007, Nature Protocols.

[46]  K. Mori,et al.  Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. , 1999, Molecular biology of the cell.

[47]  H. Tanke,et al.  COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping , 2006, Nature Protocols.

[48]  James A Thomson,et al.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. , 2011, American journal of physiology. Heart and circulatory physiology.

[49]  D. Friedlander,et al.  The congenital long QT syndrome. , 1989, The New Zealand medical journal.

[50]  Bernhard M. Schuldt,et al.  A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.

[51]  Laura Iop,et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.

[52]  Lior Gepstein,et al.  Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.

[53]  A. F. Stewart,et al.  A recombineering pipeline to make conditional targeting constructs. , 2010, Methods in enzymology.

[54]  Prashant Mali,et al.  Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. , 2009, Cell stem cell.

[55]  Jonathan A. Bernstein,et al.  Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2011, Nature.

[56]  C. Hetz.  The unfolded protein response: controlling cell fate decisions under ER stress and beyond , 2012, Nature Reviews Molecular Cell Biology.

[57]  Rene Spijker,et al.  Differentiation of Human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells , 2003, Circulation.

[58]  J. Lynch,et al.  Liquid junction potentials and small cell effects in patch-clamp analysis , 1991, The Journal of Membrane Biology.

[59]  Hiroshi Morita,et al.  The QT syndromes: long and short , 2008, The Lancet.

[60]  R. Guigó,et al.  Transcriptome genetics using second generation sequencing in a Caucasian population , 2010, Nature.

[61]  P. Marchetti,et al.  Glucose‐ and arginine‐induced insulin secretion by human pancreatic β‐cells: the role of HERG K+channels in firing and release , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[63]  R. Passier,et al.  NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes , 2011, Nature Methods.

[64]  Divya Rajamohan,et al.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European Heart Journal.

[65]  C. Mummery,et al.  Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. , 2011, Trends in molecular medicine.

[66]  M. Ackerman,et al.  Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. , 2013, Translational research : the journal of laboratory and clinical medicine.

[67]  Stefan A. Mann,et al.  hERG K(+) channels: structure, function, and clinical significance. , 2012, Physiological reviews.

[68]  K. Morgan,et al.  Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes , 2013, European heart journal.

[69]  L. Rolnitzky,et al.  Kinetin in Familial Dysautonomia Carriers: Implications for a New Therapeutic Strategy Targeting mRNA Splicing , 2009, Pediatric Research.

[70]  Katriina Aalto-Setälä,et al.  Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture , 2011, Disease Models & Mechanisms.

[71]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, The New England journal of medicine.